Barrett’s Esophagus is associated with long-term gastro-esophageal reflux disease (GERD) and is a risk factor for esophageal cancer. Current practice is to screen select patients who have multiple risk factors for esophageal cancer and monitor those patients diagnosed with Barrett's Esophagus for development of precancerous change (dysplasia). Patients who are at higher risk of progressing to esophageal cancer may benefit from endoscopic therapy.
ISDE endorsed and sponsored the following research:
Additional information can be found below.
Barrett's Roundtable Discussion Series
Expert roundtable discussion on the management of Barrett’s Esophagus. Roundtable Series 4 is presented in three episodes covering screening and diagnosis, assessment, and endoscopic therapy.
Listen to an open dialogue between multi-disciplinary specialists and leaders in the field, recorded during the 16th World Congress for Esophageal Diseases in Vienna, Austria.
Assessment in Barrett’s Esophagus and Risks for Progression to Cancer
Endoscopic Therapy in Barrett’s Esophagus